Project Grant S10OD038331

Award Date 7/15/25
Completion Date 7/14/26
Dollars Obligated $1
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This $635,689 Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a ZEISS LSM 980 confocal microscope with Airyscan 2 technology for the Optical Imaging Core Facility (OIF) at The University of Texas Health Science Center at San Antonio (UTHSCSA). The new confocal microscope will replace obsolete equipment and provide critical advanced imaging capabilities to support over 80 NIH-funded...
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will provide $1,197,188 to the University of Texas Health Science Center at Houston (UTHealth) to procure an Aberrior Facility Line Stimulated Emission Depletion (STED) super-resolution microscope system. This cutting-edge equipment will bolster the research efforts of 13 NIH-funded scientists at UTHealth and MD Anderson Cancer Center, enabling nanoscale 3D imaging...
The federal Project Grant award in the amount of $829,223 was provided by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351). The funding will support the purchase of a CYTOF XT mass cytometer with the Hyperion XTI imaging platform, which will be installed at the Cytometry and Cell Sorting Core at Baylor College of Medicine. The instrument will be used by a group of eleven NIH-funded investigators to analyze cell suspensions and tissue sections...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $752,359 Project Grant under the National Institutes of Health's Research Infrastructure Programs (CFDA #93.351) to purchase a state-of-the-art Thermo Fisher Scientific Invitrogen Bigfoot Full Spectrum Cell Sorter. This high-throughput, full-spectrum flow cytometer will complement UCSF's existing suite of advanced cell analysis instruments, enabling researchers to simultaneously analyze up to 35-40 parameters on...
This $949,116 Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system at the University of South Florida (USF). This cutting-edge analytical instrumentation will establish a unique omics capability at USF to support detailed, high-resolution structural analysis of low-level small molecules in complex...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $1,869,146 to the University of California, Los Angeles (UCLA) to purchase the CellXpress.AI automated cell culture system. The new instrument will enable researchers at UCLA to scale cell culture in preparation for high-throughput screening campaigns and meet the demand for genome-engineered cell lines and advanced cellular...
The Sanford Burnham Prebys Medical Discovery Institute (SBP) was awarded $907,406.58 under a Project Grant from the National Institutes of Health Office of the Director through the Research Infrastructure Programs program. The grant funds the acquisition of a NanoString GeoMx Digital Spatial Profiler, which will enable SBP researchers to quantify proteins or mRNAs in a highly multiplexed assay across tissue sections. The instrument bridges traditional spatial analyses in SBP's histology core...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $405,777 to the University of Texas Health Science Center at Houston (UTHealth) to acquire a new Nanowizard V atomic force microscope (AFM) system. The award will replace UTHealth's outdated 17-year-old AFM, enabling enhanced research capabilities in biomedical sciences across 11 investigators and multiple institutions in the...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $518,494 to the University of Hawaii at Manoa to acquire and deploy an upgraded Illumina iScan system and associated accessories for the university's Genomics and Bioinformatics Shared Resource (GBSR) laboratory. The new equipment, which includes an Infinium automated pipetting system, autoloader, and water circulator, will...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $593,598 to the University of Texas Medical Branch at Galveston (UTMB) to acquire a Waters DESI XS XEVO TQ Absolute mass spectrometry imaging system. This specialized equipment will enhance UTMB's bioimaging capabilities in drug discovery and development research across areas of infectious disease, kidney disease, and neuroscience. The award supports...

10X GENOMICS XENIUM ANALYZER - THIS GRANT APPLICATION REQUESTS FUNDS TO PURCHASE A 10X GENOMICS XENIUM ANALYZER TO ENABLE TEAMS OF WELL- FUNDED BIOMEDICAL RESEARCHERS WHO ARE EXPERIENCED IN SINGLE-CELL TRANSCRIPTOMIC APPROACH TO CONDUCT SPATIAL TRANSCRIPTOMICS AND PROTEOMICS ON TISSUE SPECIMENS AT A CELLULAR AND SUBCELLULAR RESOLUTION AT THE UNIVERSITY OF TEXAS HEALTH AT SAN ANTONIO (UTHSA). THIS INSTRUMENT WILL BE HOUSED IN THE GENOME SEQUENCING FACILITY (GSF) AT THE GREEHEY CHILDREN'S CANCER RESEARCH INSTITUTE (GCCRI), A CAMPUS-WIDE SHARED CORE FACILITY OPERATED BY A TEAM OF WELL-TRAINED AND EXPERIENCED STAFF AND BIOINFORMATICIANS SPECIALIZING IN SEQUENCING AND GENOMICS TECHNOLOGIES. SINCE ITS INCEPTION IN 2011, THE GSF, WITH A VARIETY OF HIGH-THROUGHPUT SEQUENCING AND GENOMIC INSTRUMENTS, HAS BECOME A CRITICAL COMPONENT FOR GENOMIC RESEARCH AND COLLABORATIONS WITHIN UTHSA AND SAN ANTONIO. CURRENTLY, SPATIAL TRANSCRIPTOME STUDIES ARE CONDUCTED SOLELY ON A 10X GENOMICS CYTASSIST VISIUM SYSTEM WITH LIMITED RESOLUTION AT GSF, AND THERE ARE NO OTHER ACCESSIBLE SPATIAL TRANSCRIPTOME PLATFORMS WITHIN UTHSA OR THE SURROUNDING SAN ANTONIO INSTITUTIONS. NUMEROUS BASIC, TRANSLATIONAL, CLINICAL, AND GENOMICS STUDIES AT UTHSA RELY ON A ROBUST SPATIAL TRANSCRIPTOMICS PLATFORM THAT IS AFFORDABLE, ACCESSIBLE, CAPABLE OF HIGH- RESOLUTION OUTPUT, AND SUPPORTED BY COMPREHENSIVE BIOINFORMATICS TOOLS FOR DATA ANALYSIS AND VISUALIZATION. THE REQUESTED 10X GENOMICS XENIUM ANALYZER WILL MEET THESE REQUIREMENTS, THUS ENABLING THE GSF TO PROVIDE HIGH- QUALITY SPATIAL TRANSCRIPTOMICS DATA TO SUPPORT NIH-FUNDED BIOMEDICAL RESEARCH, BENEFITING 16 MAJOR USERS WHOSE PROJECTS ARE IN AREAS SUCH AS CANCER, AGING, PAIN CONTROL, IMMUNOLOGY, DIABETES, INFECTIOUS DISEASE, AND NEURODEGENERATIVE DISEASES, AS DETAILED IN THIS PROPOSAL. OUR HISTORY AND FUTURE PLANNING DEMONSTRATE UTHSA'S STRONG COMMITMENT TO ADVANCING GENOMICS RESEARCH, FULLY SUPPORTING THIS GRANT APPLICATION BY PROVIDING THE NECESSARY RESOURCES FOR GSF'S OPERATION. ADDITIONALLY, THE NEW XENIUM ANALYZER WILL ENHANCE EDUCATIONAL PROGRAMS FOR PRE- AND POST-DOCTORAL FELLOWS, PHYSICIANS, AND RESEARCH SCIENTISTS, FOSTERING EXCELLENCE IN GENOMICS RESEARCH AND BIOINFORMATICS INNOVATIONS AT UTHSA. THUS, ACQUIRING THE 10X GENOMICS XENIUM ANALYZER WILL SIGNIFICANTLY IMPACT AND EXPEDITE NUMEROUS NIH-FUNDED INVESTIGATIONS, PROMOTE GENOMIC SCIENTIFIC COLLABORATIONS, AND ACCELERATE TRANSLATIONAL RESEARCH TO IMPROVE THE HEALTH OF THE PREDOMINANTLY HISPANIC POPULATION IN SOUTH TEXAS.

Posted 7/7/25, 12:00 AM